Giant cell arteritis as a cause of first-ever stroke

Cerebrovascular Diseases

Volumn 24, Issue 2-3, 2007, Pages 226-230

  Wiszniewska, Malgorzata ^a,b   Devuyst, Gerald ^a   Bogousslavsky, Julien ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Neurological Department   (Poland)

Author keywords

Giant cell arteritis; Stroke, first ever; Temporal arteritis

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEPARIN; METHYLPREDNISOLONE; NADROPARIN; PREDNISONE;

AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GIANT CELL ARTERITIS; HEADACHE; HEALTH CARE ORGANIZATION; HISTOLOGY; HUMAN; LATENT PERIOD; MALE; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE; TEMPORAL ARTERITIS;

ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PLATELET AGGREGATION INHIBITORS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWITZERLAND; TEMPORAL ARTERITIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34548074435     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104482     Document Type: Article

References (26)

1. Weyand C, Hafner V, Kaiser M, Goronzy J: Giant cell arteritis - a molecular approach to the multiple facets of the syndrome. Ann Med Interne (Paris) 1998;149:420-424.
2. Lahita R: Vasculitis; in Lahita R, Chiorazzi N, Reeves W (eds): Textbook of the Autoimmune Diseases. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 549-556.
3. Ferro J: Vasculitis of the central nervous system. J Neurol 1998;245:766-776.
4. Büttner T, Heye N, Przuntek H: Temporal arteritis with cerebral complications: report of four cases. Eur Neurol 1994;34:162-167.
5. Imakita M, Chicao Y, Ishibashi-Ueda H: Giant cell arteritis involving the cerebral artery. Arch Pathol Lab Med 1993;117:729-733.
6. Erro M, Aymerich N, Gállego, Olier J, Ayuso T, Lacruz F: Internal carotid stenosis and giant cell arteritis. Neurologia 2004;18:409-412.
7. Hu Z, Yang Q, Li J, Tang J, Zhan H: Cerebral infarction due to giant cell arteritis - three case reports. Angiology 2004;55:227-231.
8. Bogousslavsky J, Deruaz J, Regli F: Bilateral obstruction of internal carotid artery from giant-cell arteritis and massive infarction limited to the vertebrobasilar area. Eur Neurol 1985;24:57-61.
9. Hunder G, Bloch D, Michel B, Stevens M, Arend W, Calabrase L, Edworthy S, Fauci AS, Leavitt R, Lie J, Lightfoot R, Masi A, McShane D, Mills J, Wallace S, Zvaifler N: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-1128.
10. Hu Z, Yang Q, Zheng S, Tang J, Lu W, Xu N, Shong X, Jang B: Temporal arteritis and fever: report of a case and a clinical reanalysis of 360 cases. Angiology 2000;51:953-958.
11. Pfadenhauer K, Esser M, Weber H, Wolfle K: Vertebrobasilar ischemia in temporal arteritis: results of a prospective, clinical, ultrasonographic study. Nervenarzt 2004;4:1-10.
12. Mohan N, Kerr G: Spectrum of giant cell vasculitis. Curr Rheumatol Rep 2000;2:390-395.
13. Ward T, Levin M, Wong R: Headache caused by giant cell arteritis. Curr Treat Options Neurol 2004;6:499-505.
14. Garraway W, Whisnant J, Drury I: The continuing decline in the incidence of stroke. Mayo Clin Proc 1983;58:520-523.
15. Caselli R, Hunder G, Whisnant J: Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988;38:352-359.
16. Bogousslavsky J, van Melle G, Regli F: The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
17. Hollenhorst R, Brown J, Wagener H, et al: Neurologic aspects of temporal arteritis. Neurology 1960;10:490-498.
18. Wilkinson I, Russell R: Arteritis of the head and neck in giant cell arteritis: a pathological study to show the pattern of arterial involvement. Arch Neurol 1972;27:378-391.
19. Turney T, Garraway W, Whisnant J: The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke 1984;15:790-794.
20. Gonzalez-Gay M, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa I, Dierssen-Sotos T, Llorca J: Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004;83:342-347.
21. Ray J, Mamdani M, Geerts W: Giant cell arteritis and cardiovascular disease in older adults. Heart 2005;91:324-328.
22. Pfadenhauer K, Weber H: Ultrasonography of the temporal, periorbital and carotid arteries in the diagnosis of giant cell arteritis and its neuroophtalmological complications. Ultraschall Med 2006;27:329-335.
23. Collazos J, Garcia-Monco C, Martin A, Rodriguez J, Gomez M: Multiple stroke after initiation of steroid therapy in giant cell arteritis. Postgrad Med J 1994;70:228-230.
24. Staunton H, Stafford F, Leader M, O'Riordain D: Deterioration of giant cell arteritis with corticosteroid therapy. Arch Neurol 2000;57:581-584.
25. Espinoza L, Jara L, Silveira L: Anticardiolipin antibodies in polymyalgia rheumaticagiant cell arteritis: association with severe vascular complication. Am J Med 1991;90:474-478.
26. Cid M, Cervera R, Font J: Recurrent arterial thrombosis in a patient with giant-cell arteritis and raised anticardiolipin antibody levels. Br J Rheumatol 1988;27:164.